159 related articles for article (PubMed ID: 16207592)
1. Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population.
Hou X; Wang S; Zhou Y; Xu Z; Zou Y; Zhu X; Han M; Pang T; Han ZC
Int J Hematol; 2005 Oct; 82(3):206-9. PubMed ID: 16207592
[TBL] [Abstract][Full Text] [Related]
2. Significant Association of
Hsu PC; Pei JS; Chen CC; Chang WS; Chin YT; Huang TL; Yang JS; Wang YC; Chen JC; Hsu YN; Tsai CW; Bau DT
Anticancer Res; 2021 Oct; 41(10):4801-4806. PubMed ID: 34593429
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.
Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H
Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950
[TBL] [Abstract][Full Text] [Related]
4. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
5. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity.
El Menshawy N; El Marghany AB; Sarhan MM; Aladle DA
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2941-2947. PubMed ID: 33112552
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population.
Liu W; Zhu E; Wang R; Wang L; Gao L; Yang X; Liu T
Cancer Epidemiol; 2011 Aug; 35(4):e12-7. PubMed ID: 21185249
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC.
Deng L; Zhao XR; Pan KF; Wang Y; Deng XY; Lü YY; Cao Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jan; 34(1):16-20. PubMed ID: 11958128
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
10. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer.
Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S
Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
Forones NM; de Lima JM; de Souza LG; da Silva ID
J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
[TBL] [Abstract][Full Text] [Related]
13. CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia.
Xue Y; Rong L; Tong N; Wang M; Zhang Z; Fang Y
Int J Clin Exp Pathol; 2015; 8(9):11594-600. PubMed ID: 26617896
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
15. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
[TBL] [Abstract][Full Text] [Related]
17. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921
[TBL] [Abstract][Full Text] [Related]
19. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
20. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
